User: A 64-year-old man was brought to the emergency department for sudden-onset blurred vision in both eyes and diplopia, along with a frontal headache. On presentation, he had an altered mental status. His visual symptoms spontaneously resolved shortly after arrival. He had no fevers, chills, or focal weakness. His medical history includes hypertension, chronic kidney disease (CKD), and an abdominal aortic aneurysm repaired 7 years prior. His only medications were atenolol and aspirin. He worked as a truck driver. On physical examination, the patient was lethargic and oriented to person and place, but not to time, with difficulty in word finding. He was afebrile. BP was 145/90 mmHg, Pulse 72 bpm, RR 14 bpm, and SpO2 95% on room air. Chest auscultation revealed scattered bilateral end-inspiratory crackles. Heart sounds were normal with no murmurs. Abdominal exam was normal. Several splinter hemorrhages were noted in the nail beds of both hands and the left foot. Neurologically, he had an ataxic gait and mild dysmetria, but strength and sensation were normal. Initial labs showed a leukocyte count (TLC) of 10,300/mm³ with a striking 59% eosinophilia (Absolute Eosinophil Count ~6000/mm³). Hb was 11.8 g/dL and Platelets were 234,000/mm³. Serum creatinine was elevated at 2.5 mg/dL (no baseline available). LFT showed an AST of 62 U/L and ALP of 111 U/L, with normal bilirubin. Urinalysis showed 1+ protein with no cells or casts. Toxicology was positive for amphetamines and cannabinoids. A chest radiograph revealed bilateral apical opacities.
Hello, Chief Resident here.
Key findings include sudden transient visual loss, encephalopathy, ataxia, and splinter hemorrhages in a patient with a history of aortic aneurysm repair. Most striking is the profound peripheral eosinophilia (6000/mm³), acute kidney injury, and apical lung opacities.
The constellation of multisystem involvement (CNS, skin, kidneys) following vascular history suggests an embolic or systemic inflammatory process.
Differential Diagnoses:
Recommended Next Steps:
1. Skin/Renal Biopsy: To confirm cholesterol crystals or vasculitis.
2. Echocardiogram (TTE/TEE): Evaluate for vegetations or intracardiac thrombus.
3. MRI Brain: Assess for multifocal embolic infarcts.
4. ANCA Serology: To screen for EGPA.
5. Complement levels (C3/C4): Often low in CES.
Hello Attending Consultant here.
Top 3 Differential Diagnoses:
1. Cholesterol embolization syndrome (CES) – post-aortic surgery, splinter hemorrhages, AKI, transient binocular visual loss/diplopia, eosinophilia >5000, apical infiltrates.
2. EGPA (eosinophilic granulomatosis with polyangiitis) – eosinophilic pneumonia, CNS involvement, systemic eosinophilia.
3. Infective endocarditis with embolic shower – splinter hemorrhages, encephalopathy, lung opacities; eosinophilia atypical.
Suggestions (5 points):
1. Urgent brain MRI with DWI/ADC to confirm embolic pattern.
2. TTE/TEE plus blood cultures ×3 before antibiotics.
3. ANCA, ESR, CRP, complement levels.
4. Fundoscopic exam for Hollenhorst plaques.
5. Renal biopsy if safe; avoid contrast.
6. Hold further anticoagulation pending diagnosis.
7. Consider high-dose steroids only after infection excluded.
Concise work-up prioritizes CES given vascular history and eosinophilia.
Hello, Expert Clinician here.
Best unifying diagnosis: Cholesterol embolization syndrome (atheroembolic disease) with multisystem embolization from severe aortic atherosclerosis/prior graft disease.
Why it fits: transient visual symptoms + encephalopathy/ataxia suggest embolic CNS/retinal ischemia; splinter hemorrhages, AKI, pulmonary findings, and especially marked eosinophilia are classic for CES. Prior AAA repair is a major substrate. CES can occur spontaneously, not only after recent procedures.
Top differentials:
1. Infective endocarditis – splinter hemorrhages and embolic neuro symptoms fit, but no fever/murmur, eosinophilia is very atypical, and apical opacities are not classic.
2. EGPA / eosinophilic vasculitis – eosinophilia and lung opacities fit, but no asthma/sinus disease/neuropathy; splinter hemorrhages and vascular history point away.
3. Hypereosinophilic syndrome – can cause CNS/renal injury, but splinter hemorrhages and aortic risk make CES more likely.
Key pivot: the combination of embolic phenomena + AKI + striking eosinophilia + peripheral ischemic stigmata in a patient with major aortic disease.
Most important next move: Confirm embolic source and exclude endocarditis: obtain MRI brain, dilated funduscopic exam, blood cultures ×3, and TTE/TEE. If uncertainty persists, pursue skin/renal biopsy for cholesterol clefts. Supportive care; avoid unnecessary anticoagulation/invasive vascular procedures.
Teaching pearl: Eosinophilia in an “embolic” syndrome should immediately raise cholesterol embolization, not just allergy or vasculitis.
User: An ECG showed normal sinus rhythm with ST-segment depression and biphasic T-waves in leads V3-V6, along with low voltage in the limb leads. CT head showed only cerebral atrophy. MRI brain revealed multiple recent strokes in both hemispheres, pons, and cerebellum, consistent with an embolic source. The day after admission, his mental status and headache resolved.
Hello, Chief Resident here.
The updated findings of multifocal, bi-hemispheric, and posterior circulation strokes on MRI confirm a proximal embolic source. The ECG changes (ST-depression/biphasic T-waves) and low voltage, combined with crackles and apical opacities, strongly suggest cardiac involvement—potentially eosinophilic myocarditis or Loeffler endocarditis.
While Cholesterol Embolization Syndrome (CES) remains a strong contender due to the vascular history and eosinophilia, the spontaneous resolution of encephalopathy and the specific ECG/imaging pattern shift the focus toward a primary hypereosinophilic process causing "internal" emboli.
Differential Diagnoses:
Recommended Next Steps:
1. Transthoracic/Transesophageal Echocardiogram: Look for apical thrombi or endomyocardial thickening.
2. Troponin and Pro-BNP: Assess for active myocardial injury.
3. Blood Cultures (x3): To definitively rule out endocarditis.
4. Peripheral Blood Smear and FIP1L1-PDGFRA testing: To evaluate for primary (neoplastic) HES.
5. Fundoscopic Examination: Search for Hollenhorst plaques to confirm CES.
Hello Attending Consultant here.
Top 3 Differential Diagnoses:
1. Hypereosinophilic syndrome (HES) with Loeffler endocarditis/thromboembolism.
2. Cholesterol embolization syndrome (CES) with cardiac/aortic source.
3. EGPA with cardiac and CNS involvement.
Suggestions:
1. Urgent TTE/TEE with contrast to detect apical thrombus or endomyocardial fibrosis.
2. Serial troponin, NT-proBNP, and ECG monitoring for eosinophilic myocarditis.
3. Bone-marrow biopsy + FIP1L1-PDGFRA PCR to classify HES.
4. Fundoscopy for Hollenhorst plaques; skin biopsy if feasible for cholesterol clefts.
5. ANCA panel, ESR/CRP, complement levels.
6. Hold steroids until infection fully excluded; consider empiric imatinib if myeloid HES suspected.
7. Repeat echo in 48h if initial study negative.
Multifocal embolic infarcts plus extreme eosinophilia favor HES over CES.
Hello, Expert Clinician here.
Best current unifying diagnosis: Hypereosinophilic syndrome with eosinophilic cardiac disease (Loeffler endocarditis/eosinophilic myocarditis) causing cardioembolic strokes.
Why this now fits best: extreme eosinophilia (~6000), multiterritory embolic infarcts, ECG ischemic-like changes with low limb-lead voltage, crackles/pulmonary opacities, AKI, and splinter hemorrhages all fit eosinophilic end-organ injury with intracardiac thrombus. Rapid improvement in mentation argues transient embolic phenomena rather than progressive vasculitis/infection.
Top differentials:
1. Cholesterol embolization syndrome – fits AKI, eosinophilia, splinter hemorrhages, vascular history; but multifocal brain emboli from a central source plus cardiac ECG abnormalities favor cardiac eosinophilic disease.
2. Infective endocarditis – embolic strokes/splinters fit, but afebrile, no murmur, marked eosinophilia is very atypical.
3. EGPA – eosinophilia/lung disease/cardiac disease possible, but no asthma/sinusitis/neuropathy.
Key pivot: MRI-confirmed embolic shower plus eosinophilia and new cardiac clues.
Most important next move: Urgent TTE/TEE to look for mural/apical thrombus and endomyocardial involvement; send troponin/BNP, blood cultures, smear, ANCA, and HES studies (including FIP1L1-PDGFRA). If infection is reasonably excluded, start high-dose corticosteroids promptly.
Teaching pearl: In marked eosinophilia, embolic stroke should trigger a search for occult eosinophilic cardiac thrombosis, even without chest pain.
User: A transthoracic echocardiogram was obtained, showing normal systolic function but a large, mobile, sessile mass on the basal septal wall of the left ventricle. Cardiac biomarkers were elevated: CK-MB 24 ng/mL and Troponin I 3.90 ng/mL. ESR was markedly high at 106 mm/hr. A cosyntropin stimulation test was normal. Stool specimens were negative for parasites.
Hello, Chief Resident here.
The identification of a large, mobile left ventricular mass in the setting of extreme eosinophilia, elevated cardiac enzymes, and multifocal embolic strokes confirms a cardioembolic source. The high ESR and elevated troponin indicate active endomyocardial inflammation.
While Loeffler endocarditis (HES) is a classic cause of eosinophilic thrombi, the basal septal location is slightly atypical (usually apical). However, the systemic nature—affecting the heart, brain, kidneys, and skin—strongly supports a primary hypereosinophilic process.
Differential Diagnoses:
Recommended Next Steps:
1. Cardiac MRI: To differentiate between thrombus, vegetation, and endomyocardial fibrosis/inflammation.
2. FIP1L1-PDGFRA mutation testing: Crucial to identify myeloid-variant HES, which responds to Imatinib.
3. Blood Cultures (x3): To definitively exclude IE before starting high-dose steroids.
4. ANCA Serology: To further evaluate for EGPA.
5. Initiate High-dose Corticosteroids: Once infection is ruled out, to stabilize end-organ damage.
Hello Attending Consultant here.
Top 3 Differential Diagnoses:
1. Hypereosinophilic syndrome (myeloid variant) with Loeffler endocarditis and mural thrombus.
2. Cholesterol embolization syndrome with secondary eosinophilic myocarditis.
3. EGPA with eosinophilic endomyocarditis.
Suggestions:
1. Urgent cardiac MRI to characterize mass (thrombus vs fibrosis).
2. FIP1L1-PDGFRA PCR and bone-marrow biopsy.
3. Blood cultures ×3 and ANCA panel before immunosuppression.
4. Initiate high-dose prednisone (1 mg/kg) once infection excluded.
5. Consider imatinib if PDGFRA-positive.
6. Serial troponin/echo; therapeutic anticoagulation for thrombus.
7. Ophthalmologic exam for retinal emboli.
Cardiac mass plus eosinophilia favors HES over CES.
Hello, Expert Clinician here.
Best unifying diagnosis: Hypereosinophilic syndrome (HES) with eosinophilic endomyocardial disease/Loeffler endocarditis causing LV mural thrombus and systemic emboli.
Why it fits: marked eosinophilia, elevated troponin/CK-MB, high ESR, pulmonary opacities/crackles, AKI, splinter hemorrhages, and multiterritory embolic strokes. The mobile LV septal mass is most consistent with thrombus forming on eosinophilic endocardial injury.
Top differentials:
1. EGPA — can cause eosinophilic myocarditis, but lacks asthma, sinusitis, neuropathy, or classic vasculitic features.
2. Infective endocarditis — emboli/splinter hemorrhages fit, but LV mural mass is less typical than valvular vegetation; profound eosinophilia strongly argues against.
3. Cholesterol embolization — explains eosinophilia/AKI/emboli less well once a clear intracardiac embolic source is seen.
Key pivot: finding a mobile LV mass plus myocardial injury in the setting of severe eosinophilia.
Most important next move: Start urgent treatment for eosinophilic cardiac HES while excluding infection: obtain blood cultures, then high-dose corticosteroids promptly; begin systemic anticoagulation if no contraindication. Send FIP1L1-PDGFRA, peripheral smear, serum tryptase/B12, ANCA; consider cardiac MRI.
Teaching pearl: In HES, cardiac involvement may present first as embolic stroke from mural thrombus, even with preserved systolic function.
User: A bone marrow biopsy showed normocellular marrow with no clonal abnormalities or the FIP1L1-PDGFRα mutation. Colonoscopy for a 3 cm cecal mass revealed a tubular adenoma. Finally, an endomyocardial biopsy was performed, which revealed prominent infiltration with eosinophils and lymphocytes.
Hello, Chief Resident here.
The endomyocardial biopsy confirms eosinophilic myocarditis/Loeffler endocarditis, providing the definitive etiology for the LV thrombus, embolic strokes, and splinter hemorrhages. The absence of the FIP1L1-PDGFRα mutation and clonal marrow abnormalities classifies this as Idiopathic Hypereosinophilic Syndrome (HES), assuming other secondary causes (parasites, malignancy, or drug-induced) have been excluded.
The cecal adenoma is likely an incidental finding, though it warrants resection. The patient’s multisystem presentation—cardiac, neurologic, renal, and pulmonary—is entirely explained by eosinophil-mediated tissue damage and subsequent thromboembolism.
Differential Diagnoses:
1. Idiopathic Hypereosinophilic Syndrome (HES) (85%): Confirmed by biopsy and exclusion of clonal/secondary causes.
2. Eosinophilic Granulomatosis with Polyangiitis (EGPA) (10%): Possible, though the lack of asthma or ANCA makes it less likely than HES.
3. Paraneoplastic HES (5%): Less likely given the benign nature of the tubular adenoma.
Management Plan:
1. High-dose Corticosteroids: Initiate immediately to reduce eosinophil count and end-organ damage.
2. Anticoagulation: Essential to prevent further embolic events from the LV thrombus.
3. Heart Failure Management: Diuretics and ACE inhibitors as needed for pulmonary congestion.
4. Mepolizumab: Consider if steroid-refractory.
5. Serial Echocardiography: Monitor for resolution of the LV mass.
Hello Attending Consultant here.
Top 3 Differential Diagnoses:
1. Idiopathic hypereosinophilic syndrome (HES) with Loeffler endocarditis.
2. EGPA (limited cardiac/CNS form).
3. Secondary eosinophilic myocarditis (drug/toxin-related).
Suggestions:
1. Initiate high-dose prednisone (1 mg/kg/day) immediately.
2. Start therapeutic anticoagulation (warfarin or DOAC) for LV thrombus.
3. Add mepolizumab if steroid-refractory or relapsing.
4. Serial TTE/echo and troponin to monitor response.
5. Full ANCA panel, IgE, and repeat marrow if eosinophilia persists.
6. Polypectomy of cecal adenoma; exclude occult GI malignancy.
7. Multidisciplinary follow-up (hematology, cardiology, neurology).
Hello, Expert Clinician here.
Best unifying diagnosis: Idiopathic hypereosinophilic syndrome (HES) with eosinophilic myocarditis/Loeffler endocarditis, causing LV mural thrombus and systemic emboli (multifocal strokes, transient visual symptoms).
Why it fits: endomyocardial biopsy definitively shows eosinophilic and lymphocytic infiltration; marrow is nonclonal and FIP1L1-PDGFRA negative, supporting idiopathic/nonmyeloid HES. This explains eosinophilia, troponin elevation, LV mass, splinter hemorrhages, AKI, and pulmonary findings.
Top differentials:
1. EGPA — possible eosinophilic cardiac disease, but absence of asthma/sinus disease/neuropathy makes it less likely.
2. Secondary eosinophilic myocarditis (drug, parasite, malignancy) — stool negative, marrow nonclonal, cecal lesion is tubular adenoma only; still review exposure history carefully.
3. Infective endocarditis — now unlikely given biopsy-proven eosinophilic myocarditis and nonvalvular LV thrombus.
Key pivot: the combination of mobile LV mass + biopsy-proven eosinophilic myocarditis.
Most important next move: Immediate high-dose corticosteroids plus therapeutic anticoagulation for LV thrombus/ongoing embolic risk. Monitor eosinophil count, troponin, and serial echocardiography; consider steroid-sparing therapy (eg, mepolizumab) if refractory/relapsing.
Teaching pearl: In HES, cardiac involvement may precede classic systemic clues and can present as embolic stroke with preserved EF.
User: The final diagnosis was Hypereosinophilic Syndrome (HES) with eosinophilic endomyocarditis and intracardiac thrombus resulting in embolic strokes. He was treated with prednisone (1 mg/kg) and anticoagulation. His eosinophil count promptly normalized, and a repeat echocardiogram 2 weeks later showed resolution of the cardiac mass. Follow-up biopsy at 2 months showed healing myocarditis without eosinophils.
Resident:
Hello, Chief Resident here.
This case elegantly demonstrates the classic triad of Hypereosinophilic Syndrome (HES): extreme peripheral eosinophilia, endomyocardial infiltration (Loeffler endocarditis), and devastating thromboembolic complications.
Key Findings & Clinical Correlation:
* Cardiac: The "sessile mass" on the basal septum was a mural thrombus formed over endocardial damage. The elevated troponin and low limb-lead voltage reflected active eosinophilic myocarditis.
* Neurologic: Multifocal embolic strokes and transient visual loss (amaurosis fugax) resulted from the fragmentation of the LV thrombus.
* Systemic: Splinter hemorrhages and AKI were likely embolic rather than vasculitic, given the rapid resolution with steroids and anticoagulation.
* Pulmonary: Apical opacities likely represented eosinophilic lung disease or focal congestion.
Final Diagnosis:
1. Idiopathic Hypereosinophilic Syndrome (HES) (100%)
Management Pearl:
The rapid normalization of eosinophils and resolution of the LV thrombus with high-dose prednisone and anticoagulation confirms the steroid-sensitivity of the idiopathic variant. The absence of the FIP1L1-PDGFRA mutation was a critical prognostic marker, directing therapy toward corticosteroids rather than imatinib. This case highlights that in any patient with "embolic showers" and eosinophilia, the heart is the primary suspect.
Hello Attending Consultant here.
Top 3 Differential Diagnoses:
1. Idiopathic hypereosinophilic syndrome (HES) with Loeffler endocarditis.
2. EGPA with eosinophilic myocarditis.
3. Cholesterol embolization syndrome with secondary eosinophilic response.
Suggestions:
1. Confirm steroid response with serial AEC and troponin.
2. Continue anticoagulation 3–6 months with repeat TTE.
3. Taper prednisone slowly; add mepolizumab if relapse.
4. Screen for occult malignancy despite negative marrow.
5. Monitor renal function and repeat UA.
6. Multidisciplinary follow-up (hematology/cardiology).
7. Avoid re-exposure to amphetamines.
Hello, Expert Clinician here.
This confirms idiopathic HES with eosinophilic endomyocarditis (Loeffler endocarditis) and LV thrombus causing cardioembolic strokes.
Why it fits: biopsy-proven eosinophilic myocardial infiltration, marked eosinophilia, embolic shower on MRI, elevated troponin, and rapid disappearance of the intracardiac mass after steroids + anticoagulation. Negative marrow clonality/FIP1L1-PDGFRA argues against myeloid HES; cecal tubular adenoma is incidental.
Top differentials, now less likely:
- EGPA: lacks asthma/sinusitis/vasculitic phenotype.
- Infective endocarditis: nonvalvular LV mass, no infectious syndrome, biopsy proves eosinophilic myocarditis.
- Cholesterol embolization: cannot explain biopsy-proven myocarditis/LV thrombus.
Key pivot: the endomyocardial biopsy plus the dramatic treatment response.
Most important next move: continue a slow steroid taper with close monitoring of AEC, troponin, renal function, neurologic status, and serial echocardiography; maintain anticoagulation until thrombus resolution is durable. If relapse or steroid dependence develops, consider mepolizumab or other steroid-sparing therapy.
Teaching pearl: In HES, preserved EF does not exclude severe cardiac disease—eosinophilic endocardial injury can generate mural thrombus and embolic stroke before overt cardiomyopathy appears.